These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27529773)

  • 21. Antioxidant therapy for severe sepsis: promise and perspective.
    Pinsky MR
    Crit Care Med; 2003 Nov; 31(11):2697-8. PubMed ID: 14605544
    [No Abstract]   [Full Text] [Related]  

  • 22. Still looking for answers in COPD.
    Donohue JF
    Lancet; 2005 Apr 30-May 6; 365(9470):1518-20. PubMed ID: 15866290
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of effect of daily N-acetylcysteine supplementation on mutagen sensitivity.
    Cloos J; Bongers V; Lubsen H; Tobi H; Braakhuis BJ; Snow GB
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):941-4. PubMed ID: 8922306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rabbit model to study biochemical damage to the lens after vitrectomy: effects of N-acetylcysteine.
    Liu XC; Wang P; Yan H
    Exp Eye Res; 2009 Jun; 88(6):1165-70. PubMed ID: 19450459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
    Nguyen-Khac E; Thevenot T; Piquet MA; Benferhat S; Goria O; Chatelain D; Tramier B; Dewaele F; Ghrib S; Rudler M; Carbonell N; Tossou H; Bental A; Bernard-Chabert B; Dupas JL;
    N Engl J Med; 2011 Nov; 365(19):1781-9. PubMed ID: 22070475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.
    Burns KE; Chu MW; Novick RJ; Fox SA; Gallo K; Martin CM; Stitt LW; Heidenheim AP; Myers ML; Moist L
    JAMA; 2005 Jul; 294(3):342-50. PubMed ID: 16030279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutrients and HIV: part three - N-acetylcysteine, alpha-lipoic acid, L-glutamine, and L-carnitine.
    Patrick L
    Altern Med Rev; 2000 Aug; 5(4):290-305. PubMed ID: 10956377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial.
    Decramer M; Rutten-van Mölken M; Dekhuijzen PN; Troosters T; van Herwaarden C; Pellegrino R; van Schayck CP; Olivieri D; Del Donno M; De Backer W; Lankhorst I; Ardia A
    Lancet; 2005 Apr 30-May 6; 365(9470):1552-60. PubMed ID: 15866309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug.
    Safirstein R; Andrade L; Vieira JM
    N Engl J Med; 2000 Jul; 343(3):210-2. PubMed ID: 10900284
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic benefits of antioxidants during sepsis: is protection against oxidant-mediated tissue damage only half the story?
    Crouser ED
    Crit Care Med; 2004 Feb; 32(2):589-90. PubMed ID: 14758185
    [No Abstract]   [Full Text] [Related]  

  • 31. Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled.
    Wells AU
    Eur Respir J; 2006 Apr; 27(4):664-6. PubMed ID: 16585071
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of N-acetylcysteine on renal dysfunction in neonates undergoing the arterial switch operation.
    Aiyagari R; Gelehrter S; Bove EL; Ohye RG; Devaney EJ; Hirsch JC; Gurney JG; Charpie JR
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):956-61. PubMed ID: 19944431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant therapy for idiopathic pulmonary fibrosis.
    Hunninghake GW
    N Engl J Med; 2005 Nov; 353(21):2285-7. PubMed ID: 16306527
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
    Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.
    Ozdemir ZC; Koc A; Aycicek A; Kocyigit A
    Hemoglobin; 2014; 38(5):359-64. PubMed ID: 25222041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-oxidant N-acetylcysteine diminishes diesel exhaust-induced increased airway responsiveness in person with airway hyper-reactivity.
    Carlsten C; MacNutt MJ; Zhang Z; Sava F; Pui MM
    Toxicol Sci; 2014 Jun; 139(2):479-87. PubMed ID: 24814479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
    Serrano-Mollar A; Closa D; Prats N; Blesa S; Martinez-Losa M; Cortijo J; Estrela JM; Morcillo EJ; Bulbena O
    Br J Pharmacol; 2003 Mar; 138(6):1037-48. PubMed ID: 12684259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A lowered incidence of severe encephalopathy and cardiovascular dysfunction.
    Ytrebø LM
    Crit Care Med; 2005 May; 33(5):1181; author reply 1181-2. PubMed ID: 15891377
    [No Abstract]   [Full Text] [Related]  

  • 39. N-acetylcysteine inhibits chromium hypersensitivity in coadjuvant chromium-sensitized albino guinea pigs by suppressing the effects of reactive oxygen species.
    Wang BJ; Guo YL; Chang HY; Sheu HM; Pan MH; Lee YH; Wang YJ
    Exp Dermatol; 2010 Aug; 19(8):e191-200. PubMed ID: 20113346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, double blind trial of N-Acetylcysteine for hearing protection during stapes surgery.
    Bagger-Sjöbäck D; Strömbäck K; Hakizimana P; Plue J; Larsson C; Hultcrantz M; Papatziamos G; Smeds H; Danckwardt-Lillieström N; Hellström S; Johansson A; Tideholm B; Fridberger A
    PLoS One; 2015; 10(3):e0115657. PubMed ID: 25763866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.